Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.339
-0.001 (-0.29%)
At close: Dec 5, 2025, 4:00 PM EST
0.333
-0.007 (-1.92%)
After-hours: Dec 5, 2025, 6:18 PM EST
Akari Therapeutics, Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 2.48 | 2.6 | 3.85 | 13.25 | 9.36 | 14.06 | Upgrade
|
| Cash & Short-Term Investments | 2.48 | 2.6 | 3.85 | 13.25 | 9.36 | 14.06 | Upgrade
|
| Cash Growth | 10.60% | -32.41% | -70.98% | 41.54% | -33.40% | 145.23% | Upgrade
|
| Prepaid Expenses | 0.35 | 0.09 | 0.3 | 0.47 | 2.17 | 0.29 | Upgrade
|
| Restricted Cash | 0.06 | 0.06 | - | - | - | - | Upgrade
|
| Other Current Assets | 0.05 | 0.2 | 0.2 | 0.1 | 0.09 | 0.23 | Upgrade
|
| Total Current Assets | 2.95 | 2.95 | 4.34 | 13.82 | 11.63 | 14.58 | Upgrade
|
| Goodwill | 8.43 | 8.43 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 34 | 39.18 | 0.01 | 0.02 | 0.02 | 0.03 | Upgrade
|
| Total Assets | 45.38 | 50.56 | 4.36 | 13.83 | 11.65 | 14.6 | Upgrade
|
| Accounts Payable | 10.84 | 12.41 | 1.67 | 0.95 | 1.79 | 3.38 | Upgrade
|
| Accrued Expenses | 1.62 | 3.14 | 1.57 | 3.15 | 3.18 | 1.84 | Upgrade
|
| Short-Term Debt | 2.12 | 3.26 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0.98 | 1.11 | 1.35 | 7.95 | 1.12 | - | Upgrade
|
| Total Current Liabilities | 15.57 | 19.91 | 4.58 | 12.04 | 6.09 | 5.22 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 6.95 | 8.04 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.07 | 0.38 | - | - | - | - | Upgrade
|
| Total Liabilities | 22.69 | 28.33 | 4.58 | 12.04 | 6.09 | 5.22 | Upgrade
|
| Common Stock | 6.52 | 5.32 | 1.32 | 0.75 | 0.48 | 0.38 | Upgrade
|
| Additional Paid-In Capital | 224.37 | 212.71 | 174.75 | 167.08 | 153.13 | 139.73 | Upgrade
|
| Retained Earnings | -259.25 | -247.25 | -227.46 | -217.45 | -199.71 | -182.28 | Upgrade
|
| Comprehensive Income & Other | 51.05 | 51.46 | 51.15 | 51.42 | 51.65 | 51.55 | Upgrade
|
| Shareholders' Equity | 22.69 | 22.23 | -0.23 | 1.79 | 5.55 | 9.38 | Upgrade
|
| Total Liabilities & Equity | 45.38 | 50.56 | 4.36 | 13.83 | 11.65 | 14.6 | Upgrade
|
| Total Debt | 2.22 | 3.26 | - | - | - | - | Upgrade
|
| Net Cash (Debt) | 0.27 | -0.66 | 3.85 | 13.25 | 9.36 | 14.06 | Upgrade
|
| Net Cash Growth | -78.57% | - | -70.98% | 41.54% | -33.40% | 145.23% | Upgrade
|
| Net Cash Per Share | 0.01 | -0.06 | 0.79 | 4.24 | 4.36 | 8.90 | Upgrade
|
| Filing Date Shares Outstanding | 35.74 | 28.88 | 7.92 | 5.06 | 2.97 | 1.92 | Upgrade
|
| Total Common Shares Outstanding | 32.61 | 26.59 | 6.62 | 3.72 | 2.38 | 1.92 | Upgrade
|
| Working Capital | -12.62 | -16.96 | -0.24 | 1.77 | 5.53 | 9.36 | Upgrade
|
| Book Value Per Share | 0.70 | 0.84 | -0.03 | 0.48 | 2.33 | 4.88 | Upgrade
|
| Tangible Book Value | -19.74 | -25.38 | -0.24 | 1.77 | 5.53 | 9.36 | Upgrade
|
| Tangible Book Value Per Share | -0.61 | -0.95 | -0.04 | 0.48 | 2.32 | 4.86 | Upgrade
|
| Machinery | - | - | - | - | 0.16 | 0.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.